Universe Pharmaceuticals Inc Total Assets
Universe Pharmaceuticals Inc total assets. Based on the latest financial reports, Universe Pharmaceuticals Inc (UPC) holds total assets worth $69.30 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see UPC market cap for the company's overall valuation and market capitalisation.
Total Assets of Universe Pharmaceuticals Inc (2018–2025)
Total assets of Universe Pharmaceuticals Inc from 2018 to 2025. This chart illustrates how Universe Pharmaceuticals Inc's total assets have evolved over time, based on quarterly financial data. See Universe Pharmaceuticals Inc share price for real-time trading data and today's change.
Universe Pharmaceuticals Inc - Asset Composition Analysis
Universe Pharmaceuticals Inc Total Assets Breakdown (September 2025)
Universe Pharmaceuticals Inc total assets breakdown as of September 2025. Universe Pharmaceuticals Inc's total assets of $69.30 Million consist of 77.4% current assets and 22.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 48.5% |
| Accounts Receivable | $13.19 Million | 19.0% |
| Inventory | $2.19 Million | 3.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $296.79K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Universe Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Universe Pharmaceuticals Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Universe Pharmaceuticals Inc's current assets represent 77.4% of total assets in 2025, a decrease from 78.2% in 2018.
- Cash Position: Cash and equivalents constituted 48.5% of total assets in 2025, up from 22.1% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 19.0% of total assets.
Universe Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Universe Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Universe Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.07 | 1.63 | 3.73 |
| Quick Ratio | 3.90 | 1.44 | 3.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $40.43 Million | $12.92 Million | $45.22 Million |
Universe Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Universe Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.03 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 2.0% |
| Total Assets | $69.30 Million |
| Market Capitalization | $839.37K USD |
Valuation Analysis
Below Book Valuation: The market values Universe Pharmaceuticals Inc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Universe Pharmaceuticals Inc's assets grew by 2.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Universe Pharmaceuticals Inc (2018–2025)
The table below shows the annual total assets of Universe Pharmaceuticals Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $69.30 Million | +1.99% |
| 2024-09-30 | $67.95 Million | +27.52% |
| 2023-09-30 | $53.29 Million | -10.50% |
| 2022-09-30 | $59.54 Million | -15.12% |
| 2021-09-30 | $70.14 Million | +143.52% |
| 2020-09-30 | $28.80 Million | +61.49% |
| 2019-09-30 | $17.84 Million | -36.48% |
| 2018-09-30 | $28.08 Million | -- |
About Universe Pharmaceuticals Inc
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong … Read more